Taken together, the results of the in vitro experiments suggest that the PTPN14 knockout enhances anoikis resistance, while the in vivo experiments confirm that the PTPN14 knockout promotes tumorigenicity in breast cancer cells. The gene discussed is PTPN14; the disease is breast cancer.